Bioprinting of human pluripotent stem cell derived corneal endothelial cells with hydrazone crosslinked hyaluronic acid bioink

Pyry Grönroos,Anni Mörö,Paula Puistola,Karoliina Hopia,Maija Huuskonen,Taina Viheriälä,Tanja Ilmarinen,Heli Skottman
DOI: https://doi.org/10.1186/s13287-024-03672-w
2024-03-15
Stem Cell Research & Therapy
Abstract:Human corneal endothelial cells lack regenerative capacity through cell division in vivo Consequently, in the case of trauma or dystrophy, the only available treatment modality is corneal tissue or primary corneal endothelial cell transplantation from cadaveric donor which faces a high global shortage. Our ultimate goal is to use the state-of-the-art 3D-bioprint technology for automated production of human partial and full-thickness corneal tissues using human stem cells and functional bioinks. In this study, we explore the feasibility of bioprinting the corneal endothelium using human pluripotent stem cell derived corneal endothelial cells and hydrazone crosslinked hyaluronic acid bioink.
cell biology,medicine, research & experimental,cell & tissue engineering
What problem does this paper attempt to address?